Pioneering Mitochondrial Ion Channel Modulators for Metabolic Disorders

Developing highly tissue-penetrant mitochondrial ion channel modulators, including MPC1 and UCP2 agonists, to restore metabolic homeostasis in age-related metabolic diseases such as diabetes and obesity, as well as rare mitochondrial disorders.